Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis
Celestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Atherosclerotic plaque stabilization and regression: a review of clinical evidence
Ashish Sarraju, Steven E. Nissen
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 487-497
Closed Access | Times Cited: 28
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
Paschalis Karakasis, Nikolaos Fragakis, Κωνσταντίνος Κούσκουρας, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 841-850
Closed Access | Times Cited: 15
Impact of sodium‒glucose cotransporter‐2 inhibitors in patients with recent versus previous myocardial infarction: a systematic review and meta-analysis
Pedro Gabriel Scardini, Eric Katsuyama, A Prata, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The association between weight-adjusted waist circumference index and cardiovascular disease and mortality in patients with diabetes
Zaixiao Tao, Pengfei Zuo, Genshan Ma
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Mechanisms of fibrous cap formation in atherosclerosis
Laura Alonso-Herranz, Julián Albarrán-Juárez, Jacob Fog Bentzon
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 17
Narrative Review of Immunomodulatory and Anti-inflammatory Effects of Sodium-Glucose Cotransporter 2 Inhibitors: Unveiling Novel Therapeutic Frontiers
Sul A Lee, Leonardo V. Riella
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1601-1613
Open Access | Times Cited: 7
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure
Barbora Judita Kasperová, Miloš Mráz, Petr Svoboda, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus
Atsumasa Kurozumi, Koki Shishido, Takayoshi Yamashita, et al.
The American Journal of Cardiology (2024) Vol. 214, pp. 47-54
Open Access | Times Cited: 6
Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years?
Christopher R. Stone, Dwight D. Harris, Mark Broadwin, et al.
Methods and Protocols (2024) Vol. 7, Iss. 1, pp. 17-17
Open Access | Times Cited: 5
Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 5
Safety and Efficacy of Early SGLT2 Inhibitors Initiation in Diabetic Patients Following Acute Myocardial Infarction, a Retrospective Study
Gassan Moady, Igor Yakubovich, Shaul Atar
Journal of Cardiovascular Pharmacology and Therapeutics (2024) Vol. 29
Open Access | Times Cited: 5
High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study
正 石橋, Xiaohui Bian, Chenxi Song, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
Rehma Siddiqui, Yoshitsugu Obi, Neville R. Dossabhoy, et al.
Current Hypertension Reports (2024) Vol. 26, Iss. 12, pp. 463-474
Open Access | Times Cited: 5
Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography
Tianhao Zhang, Xuelian Gao, Tianlong Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Timing of SGLT2i initiation after acute myocardial infarction
Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes
Tafadzwa T J Kufazvinei, Jason Chai, Katherine A Boden, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 11, pp. 1241-1252
Open Access | Times Cited: 4
Computed Tomography Angiography Identified High-Risk Coronary Plaques: From Diagnosis to Prognosis and Future Management
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Panagiotis Theofilis, et al.
Diagnostics (2024) Vol. 14, Iss. 15, pp. 1671-1671
Open Access | Times Cited: 4
The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
Chung-Shu Lee, Chung‐Han Ho, Kuang‐Ming Liao, et al.
Journal of Infection and Public Health (2025), pp. 102686-102686
Open Access
Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes
Yiheng Zhang, Juanli Wu, Tao Li, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Vulnerable or High-Risk Plaque
Rocco Vergallo, Seung‐Jung Park, Gregg W. Stone, et al.
JACC. Cardiovascular imaging (2025)
Closed Access
The Role of Mesenchymal Stem Cells in Treating Diabetic Kidney Disease: Immunomodulatory Effects and Kidney Regeneration
Po-Jen Hsiao, W.H. Linda Kao, Li‐Chin Sung, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 7, pp. 1720-1735
Open Access
Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis
Abolfazl Akbari, Shiva Hadizadeh, Leida Heidary
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 3
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial
David Fitchett, Bernard Zinman, Silvio E. Inzucchi, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study
Yi‐Hsuan Lin, Chia-Hung Lin, Yu‐Chih Lin, et al.
Endocrine Practice (2024) Vol. 30, Iss. 5, pp. 424-430
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top